Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Revenue:
Licensing revenue		$ 250,000
Expenses:
Research and development	403,006	388,841
General and administrative	7,437,809	8,079,861
Depreciation and amortization	20,659	29,423
Total operating expenses	7,861,474	8,498,125
Loss before other income (expense)	(7,861,474)	(8,248,125)
Other income (expense):
Interest income	351,968	355,558
Interest expense		(1,715,733)
Other income (expense), net	(12,516)	2,676
Gain on warrant liabilities		527,025
Loss before provision for income taxes	(7,522,022)	(9,078,599)
Provision for income taxes	(800)	(800)
Loss from continuing operations	(7,522,822)	(9,079,399)
Income (loss) from Discontinued operations (Note 3)	360,133	(3,634,209)
Net loss	$ (7,162,689)	$ (12,713,608)
Basic and diluted earnings (loss) per share
Continuing operations	$ (0.23)	$ (0.29)
Discontinued operations	0.01	(0.12)
Total basic and diluted loss per share	$ (0.22)	$ (0.41)
Basic and diluted weighted average shares outstanding	33,261,938	30,947,650